TNXP - Tonix Pharmaceuticals Holding Corp.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development28,53335,50418,617
Selling General and Administrative10,43612,6589,039
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-38,969-48,162-27,656
Income from Continuing Operations
Total Other Income/Expenses Net12710840
Earnings Before Interest and Taxes-38,842-48,054-27,616
Interest Expense---
Income Before Tax-38,842-48,054-27,616
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-38,842-48,054-27,616
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-38,842-48,054-27,616
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-38,842-48,054-27,616